Abstract
Tuberculosis was first described by ancient Egyptian doctors who described clearly the clinical features and medical and surgical treatment of scrofula (Fig.8, Chap. 1). The Ancient Egyptian artists contributed to the description through their exquisite paintings, which showed spinal tuberculosis and its gibbous deformity (Fig. 1, Chap. 1). The first known sanatorium in the history of mankind was established by the Ancient Egyptians and is now open to visitors (Fig. 9, Chap. 1). Archaeological and anthropological studies indicated that tuberculosis infected the Chinese, Indo-European and pre-Columbian American tribes (Buikstra 1983; Powell 1992; Verano and Ubelaker 1992; Paulsen 1987).
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Al-Amoud M (1993) The history of tuberculosis. Saudi Med J 14:515–520
Bishop PJ (1973) Thomas Young and his’ A practical and historical treatise on consumptive diseases’, 1815. Tubercle 54:159–164
Bishop PJ (1981) Laennec: a great Student of tuberculosis. Tubercle 62:129–134,147-148
Bishop PJ, Neumann G (1970) The history of the Ziehl-Neelsen stain. Tubercle 51:196–206
British Medical Research Council (1950) Treatment of pulmonary tuberculosis with streptomycin and para-aminosalicydic acid: a Medical Research Council investigation. BMJ 2:1073–1085
British Medical Research Council (1962) Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation: a report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee. Tubercle 43:201–219
Brock TD (1999) Robert Koch-a life in medicine and bacteriology. ASM Press, Washington DC
Buikstra JE (1983) Prehistoric tuberculosis in the Americas (Evanston, 111.: Northwestern University Archeological Program, 1981) (reviewed by William D Sharpe). Trans Stud Coll Phys Phil 5(5):278–281
Calmette A (1923) Tubercle Bacillus Infection and tuberculosis in Man and Animals (trans WB Soper and GH Smith). Williams and Wilkins, Baltimore MD (quoted by Evans CC, 1998, Clinical tuberculosis, 2nd edn. Davies, Chapman and Hall Medical)
Canetti G (1962) The eradication of tuberculosis: theoretical problems and practical Solutions. Tubercle 43:301–321
Chadwick J, Mann WN (1978) Hippocratic writings. Penguin, New York, pp 117–118
Chorine V (1942) Action de I’amide nicotinique sur les bacilles du genre Mycobacterium. CR Acad Sei (Paris) 220: 150–151
Cooke RE, Dunphy DL, Blake FG (1946) Streptomycin in tuberculous meningitis. Yale J Bio Med 18:221–226
Crawfurd R (1911) The king’s evil. Oxford
Cruse JM (1999) History of medicine: the metamorphosis of scientific medicine in the ever-present past. Am J Med Sei 318:171–180
East African/British Medical Research Council (1973) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Lancet 1:1331–1338
East-African/British Medical Research Council (1974) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. Lancet 2:237–240
Feldman WH, Karlson AG, Hinshaw HC (1947) Para-aminosalicyclic acid in experimental tuberculosis in guinea pigs. Proc Sraff Meet Mayo Clin 22:473–479
Gallagher NE (1993) Islamic and Indian Medicine. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 27–34
Godfrey LG, Norman CD (1969) Surgical history of pulmonary tuberculosis: the rise and fall of various technical procedures. Can J Surg 12:381–388
Hinshaw HC (1969) Tuberculosis chemotherapy: reminiscences of early clinical trials. Scand J Respir Dis 50:197–203
Hinshaw HC, Pfuetzek and Feldman WH (1944) Chemotherapy of clinical tuberculosis with promin (Promizole). Am Rev Tuber 50:52–57
Hinshaw HC, Feldman WH, Pfuetze KH (1946) Treatment of tuberculosis with streptomycin. A summary of observations on one hundred cases. JAMA 132:778–782
Hobby GL, Lenert TF (1968) The antimycobacterial activity of Rifampin. Am Rev Respir Dis 97:713
Johnston WD (1993) Tuberculosis. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 1059–1068
Keers RY (1981) Laennec: his medical history. Thorax 36:91–94
Lehmann J (1946) Para-aminosalicyclic acid in the treatment of tuberculosis. Lancet 1:15–16
Lehmann J (1964) Twenty years afterward: historical notes on the discovery of the antituberculous effect of para-aminosalicyclic acid (PAS) and the first clinical trials. Am Rev Respir Dis 90:953–956
Lyons A, Petrucelli R (1978) Medicine, an illustrated history. Abrams, New York
Maggi N, Pallanza R, Sensi P (1965) New derivatived of Rifamycin SV. Antimic. Agents Chemother 5:765
Magner LN (ed) (1992) A history of medicine. Dekker, New York
Magner LN (1992a) Islamic medicine. In: Magner LN (ed) A history of medicine. Dekker, New York, pp 133–152
Magner LN (1992b) The scientific revolution and the circulation of the blood. In: Magner LN (ed) A history of medicine. Dekker, New York, pp 189–216
McDermott W (1969) The story of INH. J Infect Dis 119: 678–683
Meyer H, Malley J (1912) Hydrazine derivatives of pyridinecarboxyclic acids. Monatsh 33:393–414
Mitchison DA (1965) Chemotherapy of tuberculosis: a bacteriologis’s viewpoint. BMJ 1:1333–1340
Murray JF (1989) The white plague: down and out, or up and Coming? Am Rev Respir Dis 140:1788–1795
Myers JA (1977) Captain of all these men of death. Tuberculosis historical highlights. Green, St Louis
Paulsen HJ (1987) Tuberculosis in the native American: indigenous or introduced? Rev Infect Dis 9:1180–1186
Pfuetze KH, Pyle MM, Hinshaw HC et al (1955) The first clinical trial of streptomycin in human tuberculosis. Am Rev Tubercol 71:752–754
Powell ML (1992) Health and disease in the late prehistoric southeast. In: Verano JW, Ubelaker DH (eds) Disease and demography in the Americas. Smithsonian Institution Press, Washington DC, pp 41–53
Risse GB (1993) History of western medicine from Hippocrates to Germ theory. In: Kiple KF (ed) The Cambridge world history of human disease. Cambridge University Press, Cambridge, pp 11–27
Robitzek EH, Selikoff IJ (1952) Hydrazine derivatives of isonicotinic acid (Rimifon, Marsilid) in the treatment of active progressive caseous-penumonic tuberculosis. A preliminary report. Am Rev Tubercol 65:402–428
Rogers FB (1969) The rise and decline of the altitude therapy of tuberculosis. Bull Hist Med 43:1–16
Rosenblatt MB (1973) Pulmonary tuberculosis: evolution of modern therapy. Bull NY Acad Med 49: 163–196
Ryan F (1992) The Forgotten Plague: how the battle against tuberculosis was won and lost. Little Brown, Boston
Sakula A (1981) RTH Laennec 1781-1826 his life and work: a bicentenary appreciation. Thorax 36:81–90
Sensi PG, Greco AM, Ballotta R (1959/1960) Rifomycin I. isolation and properties of Rifomycin B and Rifomycin complex. Antibiot Annu 262
Verano JW, Ubelaker DH (eds) (1992) Disease and demography in the Americas. Smithsonian Institution Press, Washington DC
Weisse AB (1995) Tuberculosis: why “The white plague“? Perspect Biol Med 39:132–138
Wilson JL (1979) History of the American Thoracic Society. Am Rev Respir Dis 119:177–184
Wright KW (1988) A history of the Onondaga Sanatorium for the treatment of tuberculosis. NY State J Med 137–145
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Madkour, M.M., Al-Otaibi, K.E., Al Swailem, R. (2004). Historical Aspects of Tuberculosis. In: Madkour, M.M. (eds) Tuberculosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18937-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-18937-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62365-3
Online ISBN: 978-3-642-18937-1
eBook Packages: Springer Book Archive